Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice

Journal of the Neurological Sciences

Volumn 260, Issue 1-2, 2007, Pages 23-32

  Bannerman, P G ^a   Hahn, A ^b  

^a Shriners Hospital for Children   (United States)

^b Wyeth ^*  (United States)

Author keywords

Axonopathy; Experimental autoimmune encephalomelitis (EAE); Motor neuron (MN); Multiple sclerosis (MS)

Indexed keywords

CD11B ANTIGEN; MONOCLONAL ANTIBODY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; THY 1 ANTIGEN; YELLOW FLUORESCENT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LUMBOSACRAL SPINE; MOTONEURON; MOUSE; MULTIPLE SCLEROSIS; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; TRANSGENIC MOUSE; WHITE MATTER;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD11; ANTIGENS, THY-1; AXONS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENES, REPORTER; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MULTIPLE SCLEROSIS; MYELITIS; NEUROFILAMENT PROTEINS; RECOMBINANT FUSION PROTEINS; SPINAL CORD; STAINING AND LABELING; WALLERIAN DEGENERATION;

EID: 34547824621     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.03.020     Document Type: Article

References (59)

1. Charcot J.M. Histologie de la sclerose en plaque. Gazette de L'Hospital (Paris) vol. 41 (1868) 554-566
2. Marburg O. Die sogenannte 'akute multiple sklerose'. Jahrbuch Phychiate vol. 27 (1906) 211-312
3. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 Pt 3 (Mar 1997) 393-399
4. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., and Roberts G.W. Beta-amyloid protein (bAPP) as a marker for axonal injury after head injury. Neurosci Lett 160 (1993) 139-144
5. Trapp B.D., Peterson J., Ransahoff R.M., Rudick R., Sverre M., and Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
6. Bitsch A., Schuchardt J., Bunkowski S., Kuhlmann T., and Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123 Pt 6 (Jun 2000) 1174-1183
7. Lassmann H., Raine C.S., Antel J., and Prineas J.W. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86 2 (1998) 213-217
8. Lucchinetti C.F., and Lassman H. The neuropathology of multiple sclerosis. In: Jessen R.J., and Richardson W.D. (Eds). Glial cell development. 2nd ed (2001), Oxford University press 379-400
9. Bjartmar C., Kinkel R.P., Kidd G., Rudick R.A., and Trapp B.D. Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57 7 (Oct 9 2001) 1248-1252
10. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 3 (Sep 2001) 389-400
11. Bannerman P.G., Hahn A., Ramirez S., Morley M., Bonnemann C., Yu S., et al. Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. Brain 128 Pt 8 (Aug 2005) 1877-1886
12. Groom A.J., Smith T., and Turski L. Multiple sclerosis and glutamate. Ann N Y Acad Sci 993 (2003) 229-275
13. Pitt D., Werner C.S., and Raine C.S. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6 (2000) 67-70
14. De Stefano N., Guidi L., Stromillo M.L., Bartolozzi M.L., and Federico A. Imaging neuronal and axonal degeneration in multiple sclerosis. Neurol Sci 24 Suppl 5 (Dec 2003) S283-S286
15. Bjartmar C., and Trapp B.D. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox Res 5 1-2 (2003) 157-164
16. Bjartmar C., Kidd G., Mork S., Rudick R., and Trapp B.D. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 48 6 (Dec 2000) 893-901
17. Kornek B., Storch M.K., Weissert R., Wallstroem E., Stefferl A., Olsson T., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157 1 (2000) 267-276
18. Raine C., and Cross A.H. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 60 (1990) 714-725
19. Raine C.S., Barnett L.B., Brown A., Behar T., and McFarlin D.E. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Investig 43 2 (1980) 150-157
20. Chang T.T., Jabs C., Sobel R.A., Kuchroo V.K., and Sharpe A.H. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med 190 5 (1999) 733-740
21. Linker R.A., Maurer M., Gaupp S., Martini R., Holtmann B., Giess R., et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8 6 (2002) 620-624
22. Oliver A.R., Lyon G.M., and Ruddle N.H. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J Immunol 171 1 (2003) 462-468
23. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., and Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 168 8 (2002) 4173-4183
24. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28 1 (Oct 2000) 41-51
25. Gehrmann J., Banati R.B., Cuzner M.L., Kreutzberg G.W., and Newcombe J. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15 2 (Oct 1995) 141-151
26. Gran B., Zhang G.X., Yu S., Li J., Chen X.H., Ventura E.S., et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 169 12 (2002) 7104-7110
27. Sternberger L.A., and Sternberger N.H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci U S A 80 19 (Oct 1983) 6126-6130
28. Ray S.K., Schaecher K.E., Shields D.C., Hogan E.L., and Banik N.L. Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc 5 3 (Jul 2000) 305-311
29. Bullard D.C., Hu X., Schoeb T.R., Axtell R.C., Raman C., and Barnum S.R. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol 175 10 (Nov 15 2005) 6327-6333
30. Zhu B., Luo L., Moore G.R., Paty D.W., and Cynader M.S. Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 162 5 (May 2003) 1639-1650
31. Blumcke I., Becker A.J., Normann S., Hans V., Riederer B.M., Krajewski S., et al. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol 60 10 (Oct 2001) 984-993
32. Muller R., Heinrich M., Heck S., Blohm D., and Richter-Landsberg C. Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res 288 2 (May 1997) 239-249
33. Shafit-Zagardo B., Kress Y., Zhao M.L., and Lee S.C. A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions. J Neurochem 73 6 (Dec 1999) 2531-2537
34. Bannerman P., Hahn A., Soulika A., Gallo V., and Pleasure D. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 55 1 (Jan 1 2007) 57-64
35. Goldman J.E., and Yen S.H. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol 19 (1986) 209-223
36. Lee V.M. Disruption of the cytoskeleton in Alzheimer's disease. Curr Opin Neurobiol 5 5 (1995) 663-668
37. Trojanowski J.Q., Schmidt M.L., Shin R.W., Bramblett G.T., Rao D., and Lee V.M. Altered tau and neurofilament proteins in neuro-degenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 3 1 (1993) 45-54
38. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J., Francis G.S., et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121 Pt 8 (Aug 1998) 1469-1477
39. De Stefano N., Narayanan S., Francis G.S., Arnaoutelis R., Tartaglia M.C., Antel J.P., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 1 (Jan 2001) 65-70
40. Filippi M., Bozzali M., Rovaris M., Gonen O., Kesavadas C., Ghezzi A., et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 Pt 2 (Feb 2003) 433-437
41. Lin X., Tench C.R., Evangelou N., Jaspan T., and Constantinescu C.S. Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging 14 3 Suppl (Jul 2004) 20S-26S
42. Kanwar J.R., Kanwar R.K., and Krissansen G.W. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127 Pt 6 (Jun 2004) 1313-1331
43. Smith T., Groom B.Z., and Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 6 (2000) 62-66
44. Yuan J., Lipinski M., and Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 40 2 (Oct 9 2003) 401-413
45. Ackerley S., Grierson A.J., Banner S., Perkinton M.S., Brownlees J., Byers H.L., et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 26 2 (Jun 2004) 354-364
46. Brownlees J., Yates A., Bajaj N.P., Davis D., Anderton B.H., Leigh P.N., et al. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113 Pt 3 (Feb 2000) 401-407
47. Carriedo S.G., Yin H.Z., and Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 16 13 (Jul 1 1996) 4069-4079
48. Tsang Y.M., Chiong F., Kuznetsov D., Kasarskis E., and Geula C. Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS. Brain Res 861 1 (Apr 7 2000) 45-58
49. Veeranna, Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Grant P., et al. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 18 11 (Jun 1 1998) 4008-4021
50. Sobue G., Hashizume Y., Yasuda T., Mukai E., Kumagai T., Mitsuma T., et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative disease involving ventral horn cells. Acta Neuropathol 79 (1990) 402-408
51. Morrison B.M., Morrison J.H., and Gordon J.W. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis. J Exp Zool 282 1-2 (Sep-Oct 1 1998) 32-47
52. Ackerley S., Grierson A.J., Brownlees J., Thornhill P., Anderton B.H., Leigh P.N., et al. Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol 150 1 (Jul 10 2000) 165-176
53. Hardin-Pouzet H., Krakowski M., Bourbonniere L., Didier-Bazes M., Tran E., and Owens T. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 20 1 (May 1997) 79-85
54. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A., and Sanchez-Gomez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24 4 (Apr 2001) 224-230
55. Werner P., Pitt D., and Raine C.S. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 50 2 (2001) 169-180
56. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., et al. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J Cell Biol 161 3 (May 12 2003) 489-495
57. Shea T.B., Jung C., and Pant H.C. Does neurofilament phosphorylation regulate axonal transport?. Trends Neurosci 26 8 (Aug 2003) 397-400
58. Yabe J.T., Chylinski T., Wang F.S., Pimenta A., Kattar S.D., Linsley M.D., et al. Neurofilaments consist of distinct populations that can be distinguished by C-terminal phosphorylation, bundling, and axonal transport rate in growing axonal neurites. J Neurosci 21 7 (Apr 1 2001) 2195-2205
59. Vandenberghe W., Ihle E.C., Patneau D.K., Robberecht W., and Brorson J.R. AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability. J Neurosci 20 19 (Oct 1 2000) 7158-7166